Direct Oral Anticoagulant Concentrations in Obese and High Body Weight Patients: A Cohort Study.

CONCLUSION:  These data indicated that obese or high BW patients generally achieve therapeutic FXa inhibitor concentrations. However, further investigations assessing clinical outcomes are required.
PMID: 32862412 [PubMed - as supplied by publisher]

Source: Thrombosis and Haemostasis - August 29, 2020 Category: Hematology Authors: Martin AC, Thomas W, Mahir Z, Crowley MP, Dowling T, Breen K, Collings V, Moore GW, MacDonald S, Hunt BJ, Cohen AT Tags: Thromb Haemost Source Type: research